Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.

Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R.

Neuropharmacology. 2012 Jan;62(1):200-8. doi: 10.1016/j.neuropharm.2011.06.030. Epub 2011 Jul 23.

PMID:
21803058
2.

The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat.

Morales-Medina JC, Dominguez-Lopez S, Gobbi G, Beck-Sickinger AG, Quirion R.

Behav Brain Res. 2012 Aug 1;233(2):298-304. doi: 10.1016/j.bbr.2012.05.015. Epub 2012 May 19.

PMID:
22613731
3.

Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.

Goyal SN, Upadhya MA, Kokare DM, Bhisikar SM, Subhedar NK.

Brain Res. 2009 Apr 17;1266:45-53. doi: 10.1016/j.brainres.2009.02.033. Epub 2009 Feb 27.

PMID:
19254701
4.

Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.

Kotagale NR, Paliwal NP, Aglawe MM, Umekar MJ, Taksande BG.

Peptides. 2013 Sep;47:7-11. doi: 10.1016/j.peptides.2013.04.018. Epub 2013 Jun 28.

PMID:
23816796
5.

Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.

Desai SJ, Borkar CD, Nakhate KT, Subhedar NK, Kokare DM.

Neuroscience. 2014 Sep 26;277:818-30. doi: 10.1016/j.neuroscience.2014.07.062. Epub 2014 Aug 7.

PMID:
25106129
6.

Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat.

Morales-Medina JC, Dumont Y, Bonaventure P, Quirion R.

Neuropeptides. 2012 Dec;46(6):329-34. doi: 10.1016/j.npep.2012.09.009. Epub 2012 Oct 25.

PMID:
23103057
7.

Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.

Sato H, Skelin I, Debonnel G, Diksic M.

Brain Res Bull. 2008 Mar 28;75(5):545-55. doi: 10.1016/j.brainresbull.2007.09.005. Epub 2007 Oct 11.

PMID:
18355630
8.

Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.

Ishida H, Shirayama Y, Iwata M, Katayama S, Yamamoto A, Kawahara R, Nakagome K.

Hippocampus. 2007;17(4):271-80.

PMID:
17265460
9.

The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.

Redrobe JP, Dumont Y, Fournier A, Quirion R.

Neuropsychopharmacology. 2002 May;26(5):615-24.

10.

Regulation of neuropeptide Y in the rat amygdala following unilateral olfactory bulbectomy.

Rutkoski NJ, Lerant AA, Nolte CM, Westberry J, Levenson CW.

Brain Res. 2002 Sep 27;951(1):69-76.

PMID:
12231458
11.

Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.

Sajdyk TJ, Schober DA, Gehlert DR.

Neuropharmacology. 2002 Dec;43(7):1165-72.

PMID:
12504923
12.

Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.

Kokare DM, Dandekar MP, Chopde CT, Subhedar N.

Brain Res. 2005 May 10;1043(1-2):107-14.

PMID:
15862523
13.
14.

Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats.

Hendriksen H, Meulendijks D, Douma TN, Bink DI, Breuer ME, Westphal KG, Olivier B, Oosting RS.

Neuropharmacology. 2012 Jan;62(1):270-7. doi: 10.1016/j.neuropharm.2011.07.018. Epub 2011 Jul 22.

PMID:
21807004
15.

Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.

Taksande BG, Kotagale NR, Gawande DY, Bharne AP, Chopde CT, Kokare DM.

Eur Neuropsychopharmacol. 2014 Jun;24(6):955-63. doi: 10.1016/j.euroneuro.2013.12.002. Epub 2013 Dec 27.

PMID:
24461723
16.

Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.

Breuer ME, Groenink L, Oosting RS, Westenberg HG, Olivier B.

Biol Psychiatry. 2007 Apr 15;61(8):990-5. Epub 2006 Dec 4.

PMID:
17141743
17.

Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala.

Sajdyk TJ, Schober DA, Smiley DL, Gehlert DR.

Pharmacol Biochem Behav. 2002 Mar;71(3):419-23.

PMID:
11830176
18.

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.

Shoblock JR, Welty N, Nepomuceno D, Lord B, Aluisio L, Fraser I, Motley ST, Sutton SW, Morton K, Galici R, Atack JR, Dvorak L, Swanson DM, Carruthers NI, Dvorak C, Lovenberg TW, Bonaventure P.

Psychopharmacology (Berl). 2010 Feb;208(2):265-77. doi: 10.1007/s00213-009-1726-x. Epub 2009 Dec 2.

PMID:
19953226
19.

Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.

Rangani RJ, Upadhya MA, Nakhate KT, Kokare DM, Subhedar NK.

Peptides. 2012 Feb;33(2):317-28. doi: 10.1016/j.peptides.2012.01.004. Epub 2012 Jan 16.

PMID:
22266216
20.

Olfactory bulbectomy increases food intake and hypothalamic neuropeptide Y in obesity-prone but not obesity-resistant rats.

Primeaux SD, Barnes MJ, Bray GA.

Behav Brain Res. 2007 Jun 18;180(2):190-6. Epub 2007 Mar 14.

Supplemental Content

Support Center